Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

DermaCult™ Keratinocyte Expansion Medium allows human skin cells to grow longer while keeping their ability to develop properly.

The early genes of a specific virus can cause abnormal skin cell growth and hair follicle changes.

Using bioreactors, scientists can grow more skin stem cells that keep their ability to regenerate skin and hair.

Negative pressure treatment improved skin thickness, blood vessel growth, and hair growth.

CRISPR-based tools improve understanding and treatment of skin development and conditions.

A woman had temporary hair loss after scalp surgery, which is a rare but self-healing condition that surgeons should recognize to avoid wrong treatment.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A position effect on the TRPS1 gene causes excessive hair growth in humans and mice.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

The enzyme is crucial for skin cell development and can be activated without proteolytic activation.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Researchers developed a new way to measure gene activity in single hair follicles and found that a specific gene's activity changes with different amounts and times of treatment.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

THBS4 helps hair grow by activating hair follicle stem cells.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

TLR4 is important in aging-related diseases and could be a new treatment target.

Autologous stem cell therapy may effectively increase hair density in Androgenetic Alopecia.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.